Literature DB >> 34273915

Pathogenic noncoding variants in the neurofibromatosis and schwannomatosis predisposition genes.

Cristina Perez-Becerril1, D Gareth Evans1, Miriam J Smith1.   

Abstract

Neurofibromatosis type 1 (NF1), type 2 (NF2), and schwannomatosis are a group of autosomal dominant disorders that predispose to the development of nerve sheath tumors. Pathogenic variants (PVs) that cause NF1 and NF2 are located in the NF1 and NF2 loci, respectively. To date, most variants associated with schwannomatosis have been identified in the SMARCB1 and LZTR1 genes, and a missense variant in the DGCR8 gene was recently reported to predispose to schwannomas. In spite of the high detection rate for PVs in NF1 and NF2 (over 90% of non-mosaic germline variants can be identified by routine genetic screening) underlying PVs for a proportion of clinical cases remain undetected. A higher proportion of non-NF2 schwannomatosis cases have no detected PV, with PVs currently only identified in around 70%-86% of familial cases and 30%-40% of non-NF2 sporadic schwannomatosis cases. A number of variants of uncertain significance have been observed for each disorder, many of them located in noncoding, regulatory, or intergenic regions. Here we summarize noncoding variants in this group of genes and discuss their established or potential role in the pathogenesis of NF1, NF2, and schwannomatosis.
© 2021 The Authors. Human Mutation published by Wiley Periodicals LLC.

Entities:  

Keywords:  intronic; neurofibromatosis; noncoding; pathogenic variants; regulatory; schwannomatosis

Mesh:

Substances:

Year:  2021        PMID: 34273915     DOI: 10.1002/humu.24261

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.700


  2 in total

1.  Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1.

Authors:  Laurence Pacot; Valerie Pelletier; Albain Chansavang; Audrey Briand-Suleau; Cyril Burin des Roziers; Audrey Coustier; Theodora Maillard; Nicolas Vaucouleur; Lucie Orhant; Cécile Barbance; Alban Lermine; Nadim Hamzaoui; Djihad Hadjadj; Ingrid Laurendeau; Laïla El Khattabi; Juliette Nectoux; Michel Vidaud; Béatrice Parfait; Hélène Dollfus; Eric Pasmant; Dominique Vidaud
Journal:  Hum Genet       Date:  2022-08-09       Impact factor: 5.881

Review 2.  Neurofibromatosis in Children: Actually and Perspectives.

Authors:  Maria Lucia Sur; Ionel Armat; Genel Sur; Diana-Cristina Pop; Gabriel Samasca; Iulia Lupan; Teodora-Larisa Timis; Ioan-Alexandru Florian; Daniel Sur
Journal:  Children (Basel)       Date:  2022-01-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.